drugset / Trial / NCT05219266

Managed Access Programs for PKC412, Midostaurin

NCT05219266 ↗

Expanded access No longer available Novartis Pharmaceuticals

Summary

The purpose of this registration is to list Managed Access Programs (MAPs) related to PKC4, Midostaurin.

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Midostaurin Small molecule — —